Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination Therapy

Since the incidence of mucosal melanoma is higher in the Japanese population compared to Caucasians, and since mucosal melanoma possesses a lower mutation burden compared to cutaneous melanoma, the efficacy of anti-PD1 antibody (Ab) monotherapy for mucosal melanoma is limited. Therefore, other targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimura, Taku, Kambayashi, Yumi, Ohuchi, Kentaro, Amagai, Ryo, Sato, Yota, Tanita, Kayo, Hashimoto, Akira, Aiba, Setsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154272/
https://www.ncbi.nlm.nih.gov/pubmed/32308589
http://dx.doi.org/10.1159/000506327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154272/
https://www.ncbi.nlm.nih.gov/pubmed/32308589
http://dx.doi.org/10.1159/000506327

Ejemplares similares